echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAMA Neurol: Effects of selective 5-serotonin reuptake inhibitors on stroke recurrence and depressive symptoms in stroke-surviving patients.

    JAMA Neurol: Effects of selective 5-serotonin reuptake inhibitors on stroke recurrence and depressive symptoms in stroke-surviving patients.

    • Last Update: 2020-09-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat post-stroke depression, but studies have found that SSRIs can lead to an increased risk of cerebral hemorrhage (ICH) in the general population.
    researchers recently looked at the effects of SSRI on ICH recurrence and depression in primary ICH survivors.
    from January 2006 to December 2017, the researchers conducted this longitudinal study at multiple level III medical centers, with an average follow-up time of 53.2 months, including 1,279 primary ICH survivors (1,049 whites, 89 blacks, 77 Hispanics, and 64 other races/ethnicities).
    researchers conducted single- and multivariate analyses of ICH recurrence risk and severity of depression, including a subset analysis of one or more factors associated with a high ICH recurrence risk: (1) large leaf ICH;
    age of participants was 71.3 years, of which 602 were women (47 per cent).
    treatment of ICH survivors with SSRI was associated with an increased risk of ICH recurrence (HR=1.31), but post-ICH depressive symptoms (OR=1.53) were also alleviated.
    In high-risk populations with ICH recurrence (HR=1.79), the risk of recurrence of cerebral hemorrhage from taking SSRIs increased further compared to all other ICH survivors (1.20), there was no significant difference in improving depressive symptoms.
    treatment with selective 5-serotonin reuptake inhibitors after primary cerebral hemorrhage may relieve depressive symptoms in patients, but increase the risk of recurrence of hemorrhagic stroke.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.